Q2 revenue rises 14.9%; H1 profit jumps 33.9%; Mumbai plan expands

Emphasis Of MatterResults RestatedExceptional ItemPat Growth 25pctEbitda Margin CompressionResults View source PDF Explain this filing

MEDANTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-6.6%Reaction day

₹1263.00

prior close

₹1245.10

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+0.5%-7.0% vs market

Hospital peers, median of 20sector-1.1%-5.5% vs sector

On the reaction day the stock moved 7.0 pts less than Nifty Midcap 150 and 5.5 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.4

10m

-2.8

15m

-2.4

30m

-3.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-6.6+0.5-7.0-1.1-5.5

Next day

-7.2+0.9-8.1-2.2-5.0

-7.0+1.7-8.7-2.2-4.8

-5.0+1.3-6.3-2.4-2.5

-7.2+1.4-8.6-2.9-4.3

-4.4+2.1-6.5-1.9-2.5

-5.0+1.8-6.8-1.9-3.1

15d

-1.7+1.6-3.2-4.0+2.4

-8.6-1.4-7.1-8.0-0.5

-5.4-0.4-5.0-9.9+4.5

-10.1+1.5-11.6-12.3+2.1

UpDownMarket · Nifty Midcap 150Sector · Hospital peers, median of 20Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Consolidated Q2 revenue rose 14.9% to Rs 109.92 crore and profit after tax rose 21.1% to Rs 15.84 crore. H1 revenue rose 17.2% to Rs 213.01 crore and profit after tax rose 33.9% to Rs 31.74 crore. Results included Rs 3.56 crore of pre-tax exceptional gains. The Mumbai hospital plan expands from 500 to 750 beds, lifting project cost to Rs 1,530 crore. Prior periods were restated after the Medanta Holdings merger.

Likely market impact

Profit growth supports the stock, but weaker operating margins, one-off gains and a Rs 330 crore project cost rise may weigh on it.